184 related articles for article (PubMed ID: 21047425)
21. Suppression of tumor growth and metastasis by simultaneously blocking vascular endothelial growth factor (VEGF)-A and VEGF-C with a receptor-immunoglobulin fusion protein.
Zhang D; Li B; Shi J; Zhao L; Zhang X; Wang C; Hou S; Qian W; Kou G; Wang H; Guo Y
Cancer Res; 2010 Mar; 70(6):2495-503. PubMed ID: 20197464
[TBL] [Abstract][Full Text] [Related]
22. Delphinidin is a novel inhibitor of lymphangiogenesis but promotes mammary tumor growth and metastasis formation in syngeneic experimental rats.
Thiele W; Rothley M; Teller N; Jung N; Bulat B; Plaumann D; Vanderheiden S; Schmaus A; Cremers N; Göppert B; Dimmler A; Eschbach V; Quagliata L; Thaler S; Marko D; Bräse S; Sleeman JP
Carcinogenesis; 2013 Dec; 34(12):2804-13. PubMed ID: 23975834
[TBL] [Abstract][Full Text] [Related]
23. Blocking Fibroblast Growth Factor receptor signaling inhibits tumor growth, lymphangiogenesis, and metastasis.
Larrieu-Lahargue F; Welm AL; Bouchecareilh M; Alitalo K; Li DY; Bikfalvi A; Auguste P
PLoS One; 2012; 7(6):e39540. PubMed ID: 22761819
[TBL] [Abstract][Full Text] [Related]
24. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis.
Skobe M; Hawighorst T; Jackson DG; Prevo R; Janes L; Velasco P; Riccardi L; Alitalo K; Claffey K; Detmar M
Nat Med; 2001 Feb; 7(2):192-8. PubMed ID: 11175850
[TBL] [Abstract][Full Text] [Related]
25. Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases.
García-Caballero M; Paupert J; Blacher S; Van de Velde M; Quesada AR; Medina MA; Noël A
J Hematol Oncol; 2017 Jun; 10(1):122. PubMed ID: 28629427
[TBL] [Abstract][Full Text] [Related]
26. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
[TBL] [Abstract][Full Text] [Related]
27. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
Wong SY; Haack H; Crowley D; Barry M; Bronson RT; Hynes RO
Cancer Res; 2005 Nov; 65(21):9789-98. PubMed ID: 16267000
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via VEGF-C.
Liu H; Yang Y; Xiao J; Lv Y; Liu Y; Yang H; Zhao L
Anat Rec (Hoboken); 2009 Oct; 292(10):1577-83. PubMed ID: 19685508
[TBL] [Abstract][Full Text] [Related]
29. Oral administration of benzyl-isothiocyanate inhibits solid tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells in BALB/c mice.
Kim EJ; Hong JE; Eom SJ; Lee JY; Park JH
Breast Cancer Res Treat; 2011 Nov; 130(1):61-71. PubMed ID: 21170677
[TBL] [Abstract][Full Text] [Related]
30. Blockade of FLT4 suppresses metastasis of melanoma cells by impaired lymphatic vessels.
Lee JY; Hong SH; Shin M; Heo HR; Jang IH
Biochem Biophys Res Commun; 2016 Sep; 478(2):733-8. PubMed ID: 27507214
[TBL] [Abstract][Full Text] [Related]
31. The lymphangiogenesis inhibitor esVEGFR-2 in human embryos: expression in sympatho-adrenal tissues and differentiation-induced up-regulation in neuroblastoma.
Becker J; Fröhlich J; Hansen J; Zelent C; Perske C; Wilting J
Histol Histopathol; 2012 Jun; 27(6):721-33. PubMed ID: 22473693
[TBL] [Abstract][Full Text] [Related]
32. Intratumoral administration of endostatin plasmid inhibits vascular growth and perfusion in MCa-4 murine mammary carcinomas.
Ding I; Sun JZ; Fenton B; Liu WM; Kimsely P; Okunieff P; Min W
Cancer Res; 2001 Jan; 61(2):526-31. PubMed ID: 11212245
[TBL] [Abstract][Full Text] [Related]
33. SAR131675, a potent and selective VEGFR-3-TK inhibitor with antilymphangiogenic, antitumoral, and antimetastatic activities.
Alam A; Blanc I; Gueguen-Dorbes G; Duclos O; Bonnin J; Barron P; Laplace MC; Morin G; Gaujarengues F; Dol F; Hérault JP; Schaeffer P; Savi P; Bono F
Mol Cancer Ther; 2012 Aug; 11(8):1637-49. PubMed ID: 22584122
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of breast cancer growth and metastasis by a biomimetic peptide.
Lee E; Lee SJ; Koskimaki JE; Han Z; Pandey NB; Popel AS
Sci Rep; 2014 Nov; 4():7139. PubMed ID: 25409905
[TBL] [Abstract][Full Text] [Related]
35. Effects of 6,8-Diprenylgenistein on VEGF-A-Induced Lymphangiogenesis and Lymph Node Metastasis in an Oral Cancer Sentinel Lymph Node Animal Model.
Bae MG; Hwang-Bo J; Lee DY; Lee YH; Chung IS
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466636
[TBL] [Abstract][Full Text] [Related]
36. A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivo.
Li XP; Jing W; Sun JJ; Liu ZY; Zhang JT; Sun W; Zhu W; Fan YZ
BMC Cancer; 2015 Jul; 15():527. PubMed ID: 26187792
[TBL] [Abstract][Full Text] [Related]
37. Deguelin--an inhibitor to tumor lymphangiogenesis and lymphatic metastasis by downregulation of vascular endothelial cell growth factor-D in lung tumor model.
Hu J; Ye H; Fu A; Chen X; Wang Y; Chen X; Ye X; Xiao W; Duan X; Wei Y; Chen L
Int J Cancer; 2010 Nov; 127(10):2455-66. PubMed ID: 20162567
[TBL] [Abstract][Full Text] [Related]
38. Endostatin inhibits lymph node metastasis by a down-regulation of the vascular endothelial growth factor C expression in tumor cells.
Fukumoto S; Morifuji M; Katakura Y; Ohishi M; Nakamura S
Clin Exp Metastasis; 2005; 22(1):31-8. PubMed ID: 16132576
[TBL] [Abstract][Full Text] [Related]
39. In vivo electrogene transfer of interleukin-12 inhibits tumor growth and lymph node and lung metastases in mouse mammary carcinomas.
Shibata MA; Ito Y; Morimoto J; Kusakabe K; Yoshinaka R; Otsuki Y
J Gene Med; 2006 Mar; 8(3):335-52. PubMed ID: 16345101
[TBL] [Abstract][Full Text] [Related]
40. Endogenous angiogenesis inhibitor vasohibin1 exhibits broad-spectrum antilymphangiogenic activity and suppresses lymph node metastasis.
Heishi T; Hosaka T; Suzuki Y; Miyashita H; Oike Y; Takahashi T; Nakamura T; Arioka S; Mitsuda Y; Takakura T; Hojo K; Matsumoto M; Yamauchi C; Ohta H; Sonoda H; Sato Y
Am J Pathol; 2010 Apr; 176(4):1950-8. PubMed ID: 20133819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
